ارسل ملاحظاتك

ارسل ملاحظاتك لنا







Calprotectin as a Method of Screening for Irritable Bowel Syndrome

المصدر: المجلة العربية للنشر العلمي
الناشر: مركز البحث وتطوير الموارد البشرية - رماح
المؤلف الرئيسي: Arnous, Nahed Jamal (Author)
مؤلفين آخرين: El-Sherif, Taha (Co-Author) , Tadjine, Yasmine (Co-Author)
المجلد/العدد: ع55
محكمة: نعم
الدولة: الأردن
التاريخ الميلادي: 2023
الشهر: آيار
الصفحات: 29 - 34
ISSN: 2663-5798
رقم MD: 1437521
نوع المحتوى: بحوث ومقالات
اللغة: الإنجليزية
قواعد المعلومات: EduSearch, HumanIndex
مواضيع:
رابط المحتوى:
صورة الغلاف QR قانون

عدد مرات التحميل

3

حفظ في:
المستخلص: Irritable bowel Syndrome (IBS) is a very common functional digestive disorder which affects 10-15% of the population. It mainly affects young and middle-aged adults, especially in western industrial societies. The main symptoms consist of cramps, bloating and bowel motion alterations. Although it is a benign digestive disorder, investigations to rule out organic digestive disease are of utmost importance, and for that reason having a sensible maker or investigation is very important to avoid invasive, complicated or expensive procedures. Calprotectin, a protein biomarker which is present in human faeces during gastrointestinal inflammatory processes, has shown promise as a good method to rule out inflammatory digestive disease. Investigating calprotectin levels may therefore be a cheap and effective method for distinguishing inflammatory from non-inflammatory Bowel diseases. Therefore, the purpose of this scoping review is to compile the most recent evidence on the use of calprotectin levels in general practice.

ISSN: 2663-5798